Interview with Olessia Akimtseva, Senior Associate, CMS Russia
How would you describe CMS’s own presence in the life sciences field in Russia, and what unique competitive advantages does the firm bring to this area of practice? Over the…
Address: CMS in Russia, 119019 Moscow, Gogolevsky boulevard, 11 ,Russia
Tel: +7 495 786 4000
Web: http://www.cmslegal.ru/Pages/default.aspx
CMS has been working in the Russian market since 1992 and has developed recognised expertise advising clients on cross border and domestic legal and tax issues. With more than 90 lawyers, including 20 partners, we offer clients a fully integrated service in Russia and have the know-how, experience and resources to tackle the most complex matters. Knowledge of different legal systems ensures we are well qualified to consult clients on Russian and international law and, thus, to give them tailor-made advice on their projects.
Our principles
As a leading European provider of solutions for legal and tax issues in Russia, we are committed to the highest quality of service, to the interests of our clients and to the development of our people. Our approach is rooted in knowledge of the industry and is geared towards achieving the desired commercial result for clients, quickly and cost-effectively.
We work hard to be a truly client focused law firm. This means understanding the unique needs and challenges of each market sector and providing a tailored service addressing specific concerns and requirements. We focus on building long-term relationships with clients and are responsive, flexible and pro-active.
We are international in our outlook but also recognise that CMS best interests are served by maintaining strong local practices. We are convinced that having a regional presence is crucial to understanding client needs, thereby enabling us to develop and implement tailored solutions.
Adding value
Whilst the quality of our legal and tax advice is of the utmost importance, we place great significance on building relationship and adding value to a client’s firm.
Our experts regularly organise client seminars, workshops and training sessions on specific legal issues. We become a true business partner to our clients and provide them with the necessary insight on national and international legal developments that impact their business.
Our advice often goes beyond legal and taxation aspects as we strive to provide an insight into the business implications of legal decisions, corporate culture and specifics of local business approaches.
Expertise
Automotive
Banking & Finance
Commercial Law
Competition & EU
Consumer Products
Corporate
Dispute Resolution
Employment & Pensions
Energy
German Initiative
Hotels & Leisure
Infrastructure & Project Finance
Insurance & Funds
Intellectual Property
Japanese desk
Lifesciences
Private Equity
Real Estate & Construction
Tax
Technology, Media & Telecoms
How would you describe CMS’s own presence in the life sciences field in Russia, and what unique competitive advantages does the firm bring to this area of practice? Over the…
You founded this business in 2003, and it has since grown to encompass five offices and over 250 experts. Can you tell our readers a bit about the history behind…
The following is an interview with Dr. Pavlovich, as well as Dr. Sergey Smirnov, Director, Business Development and Operations, CEE, CIS and Russia Quintiles very recently announced the launch of…
The following is an interview with Dr. Smirnov, as well as Dr. Dmitri Pavlovich, Director, Clinical Operations Russia Quintiles very recently announced the launch of its first commercial project in…
GSK CEO Andrew Witty has said that GSK must move away from selling “white pills in Western markets” in order to offset widespread generic erosion. This means diversifying the company’s…
The following is joint interview of Mr. Vayntrub and Regina Karymova, General Manager of Invar Mr. Vayntrub, you founded Invar in 1991, and began to capitalize on foreign investment in…
Pepeliaev, Goltsblat & Partners and the major UK firm Berwin Leighton Paisner (BLP). It calls itself the first international Russian law firm. Can you explain to our readers the rationale…
You have lead this company since its beginnings in 2003, when it acquired ICN pharmaceuticals. In 2007, Pharmstandard carried out an IPO of 43% of its shares. How has the…
You were working for GSK since 2003 before joining Galderma this year. Some within the industry might view Galderma as a step down from the third-ranked pharmaceutical company in the…
Janssen recently signed memorandums of understanding with both the Skolkovo Foundation and ChemRar. Can you describe the strategic parameters and intended outcomes of these agreements? How do they factor into…
Mr. Demidov, you are one of the pioneers of market research studies in Russia. There is a quote you like to use: ‘Market research is a business in the United…
How would you describe CMS’s own presence in the life sciences field in Russia, and what unique competitive advantages does the firm bring to this area of practice? Over the…
With the announcement of the Pharma 2020 strategy to develop the domestic pharmaceutical industry, multinational companies have pledged an excess of $1Bn in investment into local infrastructure. Servier, however, preempted…
See our Cookie Privacy Policy Here
